Risk of second malignant neoplasms in women and girls with germ cell tumors

Z. Liao, M. C. Rodrigues, J. N. Poynter, J. F. Amatruda, C. Rodriguez-Galindo, A. Lindsay Frazier

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: While an elevated risk of second malignant neoplasms (SMNs) has been observed in men treated for germ cell tumors (GCTs), risk of SMNs have not been quantified in adult women or in girls treated for GCTs. Patients and methods: One-year survivors of primary GCTs diagnosed between January 1980 and December 2012 were identified from Surveillance, Epidemiology, and End Results (SEER 9) registries. Risk of SMNs was calculated using SEER*Stat. Results: Among 1507 patients, a total of 47 SMNs were identified. The overall risk of SMNs was not elevated in females overall or in females treated for GCT during adulthood although SMN sites (pancreas, soft tissue, bladder, kidney, and thyroid) and trends were comparable with those inmen. There were too few childhood GCT cases with SMNs for further analysis. Conclusions: Unlike men, women treated for GCTs did not have a statistically significant elevated risk of SMNs [standardized incidence ratio=1.11; 95% confidence interval (CI)=0.81-1.47]. The fact that SMNs in women occur in sites similar to those observed in men indicate that long-term follow-up of a larger cohort of females treated for GCT is warranted.

Original languageEnglish (US)
Pages (from-to)329-332
Number of pages4
JournalAnnals of Oncology
Volume28
Issue number2
DOIs
StatePublished - 2017

Fingerprint

Second Primary Neoplasms
Germ Cell and Embryonal Neoplasms
Neoplasms by Site
Survivors
Registries
Pancreas
Thyroid Gland
Epidemiology
Urinary Bladder
Confidence Intervals
Kidney
Incidence

Keywords

  • Germ cell tumors
  • Ovarian cancers
  • Second cancers
  • SEER

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

Liao, Z., Rodrigues, M. C., Poynter, J. N., Amatruda, J. F., Rodriguez-Galindo, C., & Frazier, A. L. (2017). Risk of second malignant neoplasms in women and girls with germ cell tumors. Annals of Oncology, 28(2), 329-332. https://doi.org/10.1093/annonc/mdw609

Risk of second malignant neoplasms in women and girls with germ cell tumors. / Liao, Z.; Rodrigues, M. C.; Poynter, J. N.; Amatruda, J. F.; Rodriguez-Galindo, C.; Frazier, A. Lindsay.

In: Annals of Oncology, Vol. 28, No. 2, 2017, p. 329-332.

Research output: Contribution to journalArticle

Liao, Z, Rodrigues, MC, Poynter, JN, Amatruda, JF, Rodriguez-Galindo, C & Frazier, AL 2017, 'Risk of second malignant neoplasms in women and girls with germ cell tumors', Annals of Oncology, vol. 28, no. 2, pp. 329-332. https://doi.org/10.1093/annonc/mdw609
Liao Z, Rodrigues MC, Poynter JN, Amatruda JF, Rodriguez-Galindo C, Frazier AL. Risk of second malignant neoplasms in women and girls with germ cell tumors. Annals of Oncology. 2017;28(2):329-332. https://doi.org/10.1093/annonc/mdw609
Liao, Z. ; Rodrigues, M. C. ; Poynter, J. N. ; Amatruda, J. F. ; Rodriguez-Galindo, C. ; Frazier, A. Lindsay. / Risk of second malignant neoplasms in women and girls with germ cell tumors. In: Annals of Oncology. 2017 ; Vol. 28, No. 2. pp. 329-332.
@article{6a965802d6dd44aa94a181b558856822,
title = "Risk of second malignant neoplasms in women and girls with germ cell tumors",
abstract = "Background: While an elevated risk of second malignant neoplasms (SMNs) has been observed in men treated for germ cell tumors (GCTs), risk of SMNs have not been quantified in adult women or in girls treated for GCTs. Patients and methods: One-year survivors of primary GCTs diagnosed between January 1980 and December 2012 were identified from Surveillance, Epidemiology, and End Results (SEER 9) registries. Risk of SMNs was calculated using SEER*Stat. Results: Among 1507 patients, a total of 47 SMNs were identified. The overall risk of SMNs was not elevated in females overall or in females treated for GCT during adulthood although SMN sites (pancreas, soft tissue, bladder, kidney, and thyroid) and trends were comparable with those inmen. There were too few childhood GCT cases with SMNs for further analysis. Conclusions: Unlike men, women treated for GCTs did not have a statistically significant elevated risk of SMNs [standardized incidence ratio=1.11; 95{\%} confidence interval (CI)=0.81-1.47]. The fact that SMNs in women occur in sites similar to those observed in men indicate that long-term follow-up of a larger cohort of females treated for GCT is warranted.",
keywords = "Germ cell tumors, Ovarian cancers, Second cancers, SEER",
author = "Z. Liao and Rodrigues, {M. C.} and Poynter, {J. N.} and Amatruda, {J. F.} and C. Rodriguez-Galindo and Frazier, {A. Lindsay}",
year = "2017",
doi = "10.1093/annonc/mdw609",
language = "English (US)",
volume = "28",
pages = "329--332",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "Oxford University Press",
number = "2",

}

TY - JOUR

T1 - Risk of second malignant neoplasms in women and girls with germ cell tumors

AU - Liao, Z.

AU - Rodrigues, M. C.

AU - Poynter, J. N.

AU - Amatruda, J. F.

AU - Rodriguez-Galindo, C.

AU - Frazier, A. Lindsay

PY - 2017

Y1 - 2017

N2 - Background: While an elevated risk of second malignant neoplasms (SMNs) has been observed in men treated for germ cell tumors (GCTs), risk of SMNs have not been quantified in adult women or in girls treated for GCTs. Patients and methods: One-year survivors of primary GCTs diagnosed between January 1980 and December 2012 were identified from Surveillance, Epidemiology, and End Results (SEER 9) registries. Risk of SMNs was calculated using SEER*Stat. Results: Among 1507 patients, a total of 47 SMNs were identified. The overall risk of SMNs was not elevated in females overall or in females treated for GCT during adulthood although SMN sites (pancreas, soft tissue, bladder, kidney, and thyroid) and trends were comparable with those inmen. There were too few childhood GCT cases with SMNs for further analysis. Conclusions: Unlike men, women treated for GCTs did not have a statistically significant elevated risk of SMNs [standardized incidence ratio=1.11; 95% confidence interval (CI)=0.81-1.47]. The fact that SMNs in women occur in sites similar to those observed in men indicate that long-term follow-up of a larger cohort of females treated for GCT is warranted.

AB - Background: While an elevated risk of second malignant neoplasms (SMNs) has been observed in men treated for germ cell tumors (GCTs), risk of SMNs have not been quantified in adult women or in girls treated for GCTs. Patients and methods: One-year survivors of primary GCTs diagnosed between January 1980 and December 2012 were identified from Surveillance, Epidemiology, and End Results (SEER 9) registries. Risk of SMNs was calculated using SEER*Stat. Results: Among 1507 patients, a total of 47 SMNs were identified. The overall risk of SMNs was not elevated in females overall or in females treated for GCT during adulthood although SMN sites (pancreas, soft tissue, bladder, kidney, and thyroid) and trends were comparable with those inmen. There were too few childhood GCT cases with SMNs for further analysis. Conclusions: Unlike men, women treated for GCTs did not have a statistically significant elevated risk of SMNs [standardized incidence ratio=1.11; 95% confidence interval (CI)=0.81-1.47]. The fact that SMNs in women occur in sites similar to those observed in men indicate that long-term follow-up of a larger cohort of females treated for GCT is warranted.

KW - Germ cell tumors

KW - Ovarian cancers

KW - Second cancers

KW - SEER

UR - http://www.scopus.com/inward/record.url?scp=85019589829&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019589829&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdw609

DO - 10.1093/annonc/mdw609

M3 - Article

C2 - 27864217

AN - SCOPUS:85019589829

VL - 28

SP - 329

EP - 332

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 2

ER -